|
|
Registry of biomedical companies:
[3] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 449 active entries
Lochhamer Str. 11
Martinsried, 82152, Bavaria
Phone: +49-89-89 56 32-0 Fax: +49-89-89 56 32-20 Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.
Description:
A biopharmaceutical product company, MediGene AG is focussed on the discovery, development and commercialisation of high value molecular therapeutics. With strong backing from Europe's leading finance houses and venture capitalists, MediGene's experienced management and skilled research teams have brought together a unique combination of recombinant tumour vaccines and novel targets and therapeutics for cardiac diseases. The company's proprietary technologies are aimed at the treatment of prevalent cancers such as cervical and ovarian cancer and malignant melanoma, as well as the treatment of congestive heart failure. Starting in 1995, MediGene has more than 50 employees and has raised over DM 70 million. Last update of this entry: before October 1999.
|